Artemis Medicare Q1 Results: Earnings call scheduled for Aug 4, 2026

1 min read     Updated on 29 Jul 2026, 12:55 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Artemis Medicare Services Limited has scheduled a Q1 FY27 Earnings Conference Call for August 4, 2026 at 11:00 AM IST, hosted by Anand Rathi Research. The call will be attended by Managing Director Dr. Devlina Chakravarty, CFO Mr. Sanjiv Kumar Kothari, and Head of Investor Relations Mr. Rudra Narayan Acharjee. Participants can join via universal access numbers for India as well as international dial-ins for the USA, UK, Hong Kong, and Singapore. The intimation was filed on July 29, 2026 under Regulation 30 of SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
46855531

*this image is generated using AI for illustrative purposes only.

Artemis Medicare Services Limited has announced an Earnings Conference Call for investors and analysts to discuss its operational and financial performance for Q1 FY27. The call is scheduled for Tuesday, August 4, 2026 at 11:00 AM IST, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on July 29, 2026 and signed by Poonam Makkar, Company Secretary and Compliance Officer.

Conference Call Details

The earnings call will be hosted by Anand Rathi Research. The following key details summarise the event:

Parameter: Details
Date: Tuesday, August 4, 2026
Time: 11:00 AM IST
Hosted By: Anand Rathi Research
Purpose: Q1 FY27 Operational & Financial Performance Discussion

Key Participants

The conference call will feature the following company representatives:

  • Dr. Devlina Chakravarty — Managing Director
  • Mr. Sanjiv Kumar Kothari — Chief Financial Officer
  • Mr. Rudra Narayan Acharjee — Head – Investor Relations, M&A and Organization Growth Strategy

Access Details for Participants

Investors and analysts can join the call through the following access numbers:

Region: Access Number
Universal Access (India): 022 6280 1386 / 022 7115 8287
USA: +1 866 746 2133
UK: 0808 101 1573
Hong Kong: 800 964 448
Singapore: 800 101 2045

For further information, participants may contact call co-ordinator Himanshu Binani at Office No: (022) 6626 6712 or Mobile: 7381039698. The company has noted that the schedule is subject to changes in case of exigencies on the part of analysts, investors, or the company.

Historical Stock Returns for Artemis Medicare Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.24%+9.59%+14.06%+22.59%+26.42%+685.75%

How might Artemis Medicare's Q1 FY27 revenue growth trajectory influence its valuation multiples relative to other listed healthcare service providers in India?

What specific operational metrics will Dr. Devlina Chakravarty highlight to demonstrate the scalability of the company's digital health infrastructure?

Will the CFO provide updated guidance on full-year FY27 EBITDA margins, particularly regarding cost optimization initiatives in patient acquisition?

Artemis Medicare Services
View Company Insights
View All News
like15
dislike

Artemis Medicare Services approves fund raise via equity shares

1 min read     Updated on 20 Jul 2026, 02:47 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Artemis Medicare Services Ltd shareholders have approved a special resolution to raise funds via equity shares and other eligible securities. The resolution passed with 98.68% of votes in favour, with strong support from promoters and public shareholders.

powered bylight_fuzz_icon
46084612

*this image is generated using AI for illustrative purposes only.

Artemis Medicare Services Ltd has received shareholder approval to raise capital through the issuance of equity shares and other eligible securities. The special resolution was passed with an overwhelming majority, with 98.68% of valid votes cast in favour, enabling the company to raise funds in one or more tranches.

The remote e-voting process, conducted via the National Securities Depository Limited (NSDL) platform, commenced on June 19, 2026, and concluded on July 18, 2026. A total of 194 members voted in favour of the resolution, representing 11,78,18,779 shares, while 27 members voted against it, representing 15,71,939 shares.

Voting Breakdown

The resolution received support across all shareholder categories. Promoters and the Promoter Group cast 9,24,39,640 votes entirely in favour. Public Institutions recorded 2,01,29,566 votes in favour and 15,63,775 against, while Public Non-Institutions cast 52,49,573 votes in favour and 8,164 against.

Category Votes In Favour Votes Against Total Votes Polled % In Favour
Promoter and Promoter Group 9,24,39,640 0 9,24,39,640 100.00
Public-Institutions 2,01,29,566 15,63,775 2,16,93,341 92.79
Public- Non Institutions 52,49,573 8,164 52,57,737 99.84
Total 11,78,18,779 15,71,939 11,93,90,718 98.68

Scrutinizer's Report

Ankit Tiwari & Co., Practicing Company Secretaries, acted as the scrutinizer for the postal ballot process. The report confirmed that the votes cast in favour of the resolution were more than three times the votes cast against it, satisfying the requirements for a special resolution under the Companies Act, 2013.

The total number of shareholders on the cut-off date of June 12, 2026, was 35,361. This included one shareholder holding 23,49,320 shares in an unclaimed suspense account where voting rights were frozen. The results were declared on July 20, 2026.

Historical Stock Returns for Artemis Medicare Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.24%+9.59%+14.06%+22.59%+26.42%+685.75%

What specific strategic initiatives or acquisitions does Artemis Medicare plan to fund with the newly approved capital?

How will the issuance of additional equity shares impact the company's earnings per share and existing shareholder dilution?

What is the expected timeline for the first tranche of capital raising, and which financial institutions have been mandated to manage the process?

Artemis Medicare Services
View Company Insights
View All News
like16
dislike

More News on Artemis Medicare Services

1 Year Returns:+26.42%